| Budget Amount *help |
¥17,550,000 (Direct Cost: ¥13,500,000、Indirect Cost: ¥4,050,000)
Fiscal Year 2019: ¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2018: ¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2017: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2016: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
|
|---|
| Outline of Final Research Achievements |
Understanding of latently infected HIV-1 variants circulating in developing countries has remained obscure. In this study, in collaboration with Muhimbili University of Health and Allied Sicences (Tanzania), we established a prospective HIV cohort in Dar es Salaam, Tanzania and recrutited HIV positive patients at Muhimbili National Hospital and surrounding Care and Treament Center. We analyzed virological and epidemiological characteristics as well as drug-resistance patter of latenly infected HIV-1 provirsus circulating in Tanzania. Results obtained in this study could provide useful information and insights into HIV control in resource-limiting settings such as Sub-Sahara Africa.
|
